ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 11 (3) 489-495    DOI: 10.1677/erc.1.00808
Copyright © 2004 by the Society for Endocrinology.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Cremoux, P
Right arrow Articles by Spyratos, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Cremoux, P
Right arrow Articles by Spyratos, F

Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction

P de Cremoux1, I Bieche2,3, C Tran-Perennou1, S Vignaud4, E Boudou1, B Asselain7, R Lidereau2, H Magdelénat1, V Becette5, B Sigal-Zafrani6 and F Spyratos4

1 Unité de Pharmacologie, Institut Curie, 26 rue d’Ulm, 75005 Paris, France
2 Laboratoire INSERM E0017, Centre René Huguenin, Saint Cloud, France
3 Laboratoire de Génétique Moléculaire, UPRES EA 3618, Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Paris, France
4 Laboratoire d’Oncobiologie, Centre René Huguenin, Saint Cloud, France
5 Département d’Anatomo-Pathologie, Centre René Huguenin, Saint Cloud, France
6 Service d’Anatomo-Pathologie, Institut Curie, Paris, France
7 Service de Biostatistiques, Institut Curie, Paris, France

(Requests for offprints should be addressed to P de Cremoux; Email: patricia.de-cremoux{at}curie.net)

Quantitative reverse transcription-polymerase chain reaction (RT-PCR) used to detect minor changes in specific mRNA concentrations may be associated with poor reproducibility. Stringent quality control is therefore essential at each step of the protocol, including the PCR procedure.

We performed inter-laboratory quality control of quantitative PCR between two independent laboratories, using in-house RT-PCR assays on a series of hormone-related target genes in a retrospective consecutive series of 79 breast tumors. Total RNA was reverse transcribed in a single center. Calibration curves were performed for five target genes (estrogen receptor (ER){alpha}, ERß, progesterone receptor (PR), CYP19 (aromatase) and Ki 67) and for two reference genes (human acidic ribosomal phosphoprotein PO (RPLPO) and TATA box-binding protein (TBP)). Amplification efficiencies of the calibrator were determined for each run and used to calculate mRNA expression. Correlation coefficients were evaluated for each target and each reference gene.

A good correlation was observed for all target and reference genes in both centers using their own protocols and kits (P < 0.0001). The correlation coefficients ranged from 0.90 to 0.98 for the various target genes in the two centers. A good correlation was observed between the level of expression of the ER{alpha} and the PR transcripts (P < 0.001). A weak inverse correlation was observed in both centers between ER{alpha} and ERß levels, but only when TBP was the reference gene. No other correlation was observed with other parameters.

Real-time PCR assays allow convenient quantification of target mRNA transcripts and quantification of target-derived nucleic acids in clinical specimens. This study addresses the importance of inter-laboratory quality controls for the use of a panel of real-time PCR assays devoted to clinical samples and protocols and to ensure their appropriate accuracy. This can also facilitate exchanges and multicenter comparison of data.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
P. de Cremoux, D. Rosenberg, J. Goussard, C. Bremont-Weil, F. Tissier, C. Tran-Perennou, L. Groussin, X. Bertagna, J. Bertherat, and M.-L. Raffin-Sanson
Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease
Endocr. Relat. Cancer, June 1, 2008; 15(2): 465 - 474.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. S. Sane, D. J. Buckley, A. R. Buckley, S. C. Nallani, and P. B. Desai
Role of Human Pregnane X Receptor in Tamoxifen- and 4-Hydroxytamoxifen-Mediated CYP3A4 Induction in Primary Human Hepatocytes and LS174T Cells
Drug Metab. Dispos., May 1, 2008; 36(5): 946 - 954.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Marangoni, A. Vincent-Salomon, N. Auger, A. Degeorges, F. Assayag, P. de Cremoux, L. de Plater, C. Guyader, G. De Pinieux, J.-G. Judde, et al.
A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays
Clin. Cancer Res., July 1, 2007; 13(13): 3989 - 3998.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. B. Dydensborg, E. Herring, J. Auclair, E. Tremblay, and J.-F. Beaulieu
Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon
Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G1067 - G1074.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Endocrinology.